Minimally Invasive Suprachoroidal Drainage for the Treatment of Neovascular Glaucoma

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

March 1, 2027

Conditions

Neovascular Glaucoma

Interventions

PROCEDURE

minimally invasive suprachoroidal drainage

Trial Locations (1)

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors

lead

Zhongnan Hospital

OTHER

NCT07201415 - Minimally Invasive Suprachoroidal Drainage for the Treatment of Neovascular Glaucoma | Biotech Hunter | Biotech Hunter